Table 3.
Patient | Mean effective dose (mSV) | Mean % lifetime risk |
---|---|---|
#5 | 55.8 | 0.23 |
#11 | 36.7 | 0.15 |
#12 | 25.2 | 0.10 |
#13 | 68.0 | 0.28 |
#16 | 54.5 | 0.22 |
#21 | 30.3 | 0.12 |
#28 | 84.2 | 0.35 |
#36 | 62.1 | 0.25 |
#42 | 28.4 | 0.12 |
Patient | Mean effective dose (mSV) | Mean % lifetime risk |
---|---|---|
#5 | 55.8 | 0.23 |
#11 | 36.7 | 0.15 |
#12 | 25.2 | 0.10 |
#13 | 68.0 | 0.28 |
#16 | 54.5 | 0.22 |
#21 | 30.3 | 0.12 |
#28 | 84.2 | 0.35 |
#36 | 62.1 | 0.25 |
#42 | 28.4 | 0.12 |